JOINSTAR showcased the Jet-iStar platforms (JS 800 and JS800 Plus) and its full range of twenty one Point-of-Care assays covering a range of key diseases. A major focus was its wide range of the Infectious disease tests including the patented novel Heparin Binding Protein (HBP) assay, which has been shown to play a key role in the management of Sepsis patients. The JOINSTAR booth welcomed experts, scholars and businesses from various Asian countries and there was a very positive response for the Joinstar products and offerings.